For example: Apple Inc, UTIL, Aluminum
ChemoCentryx Inc
NASDAQ:CCXI
Market Close 11/27
55.81 USD +1.81 (+3.35%)
OPEN:
53.97
DAY RANGE:
53.45 - 55.90
PE:
-10.11
PB:
37.40
PS:
15.97
WTD % -0.45
MTD % 16.27
QTD % 1.84
YTD % 41.11
* Updated at market close
ChemoCentryx Inc (NASDAQ:CCXI) opened on Nov 27, 2020 at 53.97 USD and scaled up by 3.35%. The intraday price range was 53.45 - 55.90 USD and eventually ended the session at 55.81 USD. The stock trade volume was 197,700.00 shares. The company's 52-week range is 27.47 - 65.43 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 3.84 B
Outstanding Stock 50.53 M
Dividend 0.00
Dividend Yield 0.00
EPS -0.92
YTD Change 41.11%
52 Week's Range 27.47 - 65.43
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning -10.11
Price/Book Value 37.40
Price/Sales 15.97
ROA -
ROE -
Debt/Equity 2.22
Company Self Description
ChemoCentryx Inc is a biopharmaceutical company developing new medications targeted at inflammatory disorders, autoimmune diseases, and cancer. The company's drug candidates are small molecules, which are orally administered, offering significant quality of life benefits, since patients swallow a capsule or pill instead of having to visit a clinic for an infusion or undergo an injection. It was founded in 1997 and is headquartered in Mountain View, California, United States.
Business Information
ChemoCentryx Inc
Sector Health Care
Industry Biotechnology
Exchange NASDAQ
Top Competitors (Market Close Nov 27, 2020)
  CCXI ARNA TGTX VIR
Daily Change (%) 3.35 0.61 2.71 4.33
WTD (%) -0.45 1.65 1.47 2.14
MTD (%) 16.27 -23.12 19.87 -5.73
QTD (%) 1.84 -11.89 13.19 -13.66
YTD (%) 41.11 45.09 172.88 135.71
52-Week Change (%) 87.53 35.32 287.84 287.84
Stock Performance (Market Close Nov 27, 2020)
  CCXI ARNA TGTX VIR
Daily Change (%) 3.35 0.61 2.71 4.33
WTD (%) -0.45 1.65 1.47 2.14
MTD (%) 16.27 -23.12 19.87 -5.73
QTD (%) 1.84 -11.89 13.19 -13.66
YTD (%) 41.11 45.09 172.88 135.71
52-Week Change (%) 87.53 35.32 287.84 287.84
Key Fundamentals (Market Close Nov 27, 2020)
  CCXI ARNA TGTX VIR
Market Cap 3.84 B 3.80 B 3.84 B 3.77 B
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -144.30% 72.80% -104,723.70% -104,723.70%
P/E Ratio -10.11 4.85 -4.39 -4.39
Price to Sales Ratio 15.97 3.58 4,939.61 4,939.61
Price to Book Ratio 37.40 3.17 14.14 14.14
Enterprise Value to EBITDA -14.96 -11.32 -1.55 -1.55
ROA - 60.70% -150.80% -150.80%
ROE - 66.20% -496.50% -496.50%
Debt/Equity 2.22 0.13 2.48 2.48
Asset Turnover Ratio 0.16 0.83 0.00 0.00
Current Ratio 2.82 15.40 2.03 2.03
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 42.88 M 82.50 M 11.94 M 0.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 42.88 M 82.50 M 11.94 M 0.00
Selling General & Administrative Expenses 20.41 M 16.51 M 14.71 M 14.51 M
Research & Development 62.74 M 49.50 M 37.95 M 33.18 M
Operating Income -40.27 M 16.49 M -40.72 M -47.69 M
Net Income -37.97 M 17.86 M -39.96 M -47.31 M
EPS -0.76 0.37 -0.86 -1.08
Diluted EPS -0.76 0.36 -0.86 -1.08
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 7.17 M 8.33 M 9.33 M 8.98 M
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 7.17 M 8.33 M 9.33 M 8.98 M
Selling General & Administrative Expenses 5.57 M 5.50 M 5.63 M 5.37 M
Research & Development 17.62 M 15.35 M 15.10 M 15.14 M
Operating Income -16.02 M -12.53 M -11.40 M -11.53 M
Net Income -15.15 M -11.95 M -10.79 M -10.89 M
EPS -0.26 -0.23 -0.21 -0.22
Diluted EPS -0.26 -0.23 -0.21 -0.22
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 181.38 M 179.83 M 148.69 M 72.04 M
Cash & Cash Equivalents 28.09 M 40.02 M 12.02 M 12.82 M
Total Assets 183.31 M 189.33 M 155.87 M 78.16 M
Total Current Liabilities 64.40 M 32.94 M 38.34 M 5.49 M
Total Liabilities 168.57 M 110.06 M 105.98 M 5.65 M
Shareholder's Equity 14.74 M 79.27 M 49.89 M 72.51 M
Outstanding Stock 50.53 M 48.77 M 47.81 M 44.13 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 202.00 M 226.68 M 181.38 M 176.07 M
Cash & Cash Equivalents 38.75 M 79.33 M 28.09 M 24.11 M
Total Assets 229.81 M 241.36 M 183.31 M 190.76 M
Total Current Liabilities 56.66 M 66.11 M 64.40 M 61.33 M
Total Liabilities 158.35 M 160.72 M 168.57 M 169.29 M
Shareholder's Equity 71.46 M 80.64 M 14.74 M 21.47 M
Outstanding Stock 58.05 M 52.57 M 50.53 M 50.38 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations 16.44 M 4.88 M 39.15 M -39.33 M
Capital Expenditures -838,000.00 -723,000.00 -304,000.00 -218,000.00
Net Cash Flow from Investing Activities -53.07 M 15.60 M -48.76 M 33.88 M
Net Cash Flow from Financial Activities 24.70 M 7.52 M 8.82 M 2.19 M
Free Cash Flow 15.60 M 4.16 M 38.84 M -39.55 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -14.88 M 4.88 M 39.15 M -39.33 M
Capital Expenditures -190,000.00 -46,000.00 -83,000.00 -124,000.00
Net Cash Flow from Investing Activities -28.74 M -5.14 M 13.38 M -28.50 M
Net Cash Flow from Financial Activities 3.03 M 74.68 M 5.91 M 1.41 M
Free Cash Flow -15.07 M -18.33 M -15.39 M -17.67 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio -10.11 -17.36 -14.36 46.82
Price to Sales Ratio 15.97 17.47 12.68 7.08
Price to Book Ratio 37.40 3.66 7.09 4.93
Enterprise Value to EBIT -15.00 15.00 -9.00 -7.00
Enterprise Value to EBITDA -14.96 14.89 -8.58 -7.32
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - -19.90% 11.70%
ROE - - -167.50% 35.10%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 116.99 M 146.89 M 110.36 M 66.54 M
Current Ratio 2.82 5.46 3.88 13.11
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 2.22 1.39 2.12 0.08
Asset Turnover Ratio - - 0.23 0.54
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.